Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?
- PMID: 33310087
- DOI: 10.1053/j.gastro.2020.12.013
Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?
Comment on
-
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745. N Engl J Med. 2020. PMID: 32402160 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical